搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Schizosaccharomyces pombe Uncharacterized N-acetyltransferase C550.08 (SPCC550.08) CSB-YP528881SXV
CSB-EP528881SXV
CSB-BP528881SXV
CSB-MP528881SXV
CSB-EP528881SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe KH domain-containing protein C550.14 (SPCC550.14), partial CSB-YP528882SXV
CSB-EP528882SXV
CSB-BP528882SXV
CSB-MP528882SXV
CSB-EP528882SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Glutathione S-transferase 2 (gst2) CSB-YP528883SXV
CSB-EP528883SXV
CSB-BP528883SXV
CSB-MP528883SXV
CSB-EP528883SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Probable cytosine deaminase (SPCC965.14c) CSB-YP528884SXV
CSB-EP528884SXV
CSB-BP528884SXV
CSB-MP528884SXV
CSB-EP528884SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fusarium oxysporum Mating-type protein MAT-1 (MAT1) CSB-YP528885FFO
CSB-EP528885FFO
CSB-BP528885FFO
CSB-MP528885FFO
CSB-EP528885FFO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Glutathione peroxidase (gpx1) CSB-YP528886SXV
CSB-EP528886SXV
CSB-BP528886SXV
CSB-MP528886SXV
CSB-EP528886SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Emericella nidulans cAMP-dependent protein kinase regulatory subunit (pkaR) CSB-YP528887EKF
CSB-EP528887EKF
CSB-BP528887EKF
CSB-MP528887EKF
CSB-EP528887EKF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Fimbrin (fim1), partial CSB-YP528888SXV
CSB-EP528888SXV
CSB-BP528888SXV
CSB-MP528888SXV
CSB-EP528888SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phaffia rhodozyma Aspartic protease (pr1) CSB-YP528889EUI
CSB-EP528889EUI
CSB-BP528889EUI
CSB-MP528889EUI
CSB-EP528889EUI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Kluyveromyces lactis Calmodulin (CMD1) CSB-YP528890KBK
CSB-EP528890KBK
CSB-BP528890KBK
CSB-MP528890KBK
CSB-EP528890KBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe U3 small nucleolar RNA-associated protein 20 (utp20), partial CSB-YP528891SXV
CSB-EP528891SXV
CSB-BP528891SXV
CSB-MP528891SXV
CSB-EP528891SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Protein isd11 (isd11) CSB-YP528892SXV
CSB-EP528892SXV
CSB-BP528892SXV
CSB-MP528892SXV
CSB-EP528892SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Probable prephenate dehydrogenase [NADP (+)] CSB-YP528893SXV
CSB-EP528893SXV
CSB-BP528893SXV
CSB-MP528893SXV
CSB-EP528893SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Probable glucoamylase (meu17) CSB-YP528894SXV
CSB-EP528894SXV
CSB-BP528894SXV
CSB-MP528894SXV
CSB-EP528894SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized protein C14C8.11c (SPBC14C8.11c) CSB-YP528895SXV
CSB-EP528895SXV
CSB-BP528895SXV
CSB-MP528895SXV
CSB-EP528895SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized ABC transporter ATP-binding protein C14F5.06 (SPBC14F5.06), partial CSB-YP528896SXV
CSB-EP528896SXV
CSB-BP528896SXV
CSB-MP528896SXV
CSB-EP528896SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Sorting nexin-41 (snx41), partial CSB-YP528897SXV
CSB-EP528897SXV
CSB-BP528897SXV
CSB-MP528897SXV
CSB-EP528897SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized Rab geranylgeranyltransferase C15C4.03 (SPBC15C4.03) CSB-YP528898SXV
CSB-EP528898SXV
CSB-BP528898SXV
CSB-MP528898SXV
CSB-EP528898SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe BAG family molecular chaperone regulator 1A (bag101) CSB-YP528899SXV
CSB-EP528899SXV
CSB-BP528899SXV
CSB-MP528899SXV
CSB-EP528899SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Tip elongation aberrant protein Tea4 (tea4), partial CSB-YP528900SXV
CSB-EP528900SXV
CSB-BP528900SXV
CSB-MP528900SXV
CSB-EP528900SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>